GSK and Aspen wait for clearance from competition authority
This article was originally published in Scrip
Executive Summary
Aspen Pharmacare and GlaxoSmithKline are still waiting for approval from one more South African competition body over a deal announced earlier this year which will see GSK take a 16% stake in Africa's largest pharmaceutical manufacturer and Aspen gain the rights to distribute GSK products in the country (scripnews.com, March 25th, 2009).